Rebucas, Lilifer L.
HRN: 13-34-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2022
METRONIDAZOLE 500MG (TAB)
11/24/2022
11/30/2022
ORAL
500mg
TID
Intra Uterine Fetal Death
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes